Mechanical Tissue Resuscitation for Skull Defects

This trial tests a new therapy called Mechanical Tissue Resuscitation™ (MTR®) to help remove excess fluid from individuals who have undergone partial skull removal, a procedure often necessary for brain healing. The trial aims to determine if MTR® can effectively and safely drain this fluid compared to traditional methods. Participants may qualify if they have had procedures such as craniotomy, craniectomy, or cranioplasty (types of skull surgeries) and require a drain during recovery.

As an unphased trial, this study provides participants the chance to contribute to pioneering research that could enhance recovery methods for future patients.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that Mechanical Tissue Resuscitation™ (MTR®) therapy is safe for humans. Studies have found that controlled suction can safely remove excess fluid from the brain. For instance, one study demonstrated that MTR could remove more than half of the fluid in cases of brain bleeding. Another study discovered that applying MTR immediately after an injury reduced brain swelling and preserved more brain tissue compared to those who did not receive the treatment. These findings suggest that MTR is well-tolerated and does not cause significant side effects.¹²³⁴⁵

Mechanical Tissue Resuscitation™ (MTR®) is unique because it represents a novel approach to treating skull defects, which are typically addressed with surgical interventions like bone grafts or synthetic implants. Unlike these traditional methods, MTR® uses a mechanical process to stimulate the body's natural healing mechanisms, potentially enhancing tissue regeneration without the need for invasive surgery. Researchers are excited about MTR® because it could reduce recovery times and lower the risks associated with surgical procedures, offering a less invasive and more efficient alternative for patients with skull defects.

Research has shown that Mechanical Tissue Resuscitation™ (MTR®), the treatment under study in this trial, might help treat conditions involving excess fluid in the brain. One study demonstrated that MTR® removed more than half of a brain bleed by applying controlled pressure. Another study found that using MTR® on brain injuries reduced swelling and preserved over 50% more brain tissue compared to untreated cases. These findings suggest that MTR® could help manage fluid-related brain issues and potentially improve outcomes for individuals with skull defects.¹³⁴⁵⁶